遗传风险评分在人寿保险核保中的应用

Genetic risk scores in life insurance underwriting

Journal of Health Economics · 2021
被引 26
人大 AABS 3

中文导读

研究评估遗传风险评分能否改善人寿保险核保,发现最高遗传风险组中位寿命短2.6年,表明现有评分已可提升风险分类,政策制定者需平衡利益。

Abstract

Genetic tests that predict the lifetime risk of common medical conditions are fast becoming more accurate and affordable. The life insurance industry is interested in using predictive genetic tests in the underwriting process, but more research is needed to establish whether this nascent form of genetic testing can refine the process over conventional underwriting factors. Here, we perform Cox regression of survival on a battery of genetic risk scores for common medical conditions and mortality risks in the Health and Retirement Study, without returning results to participants. Adjusted for covariates in a relevant insurance scenario, the scores could improve mortality risk classification by identifying 2.6 years shorter median lifespan in the highest decile of total genetic liability. We conclude that existing genetic risk scores can already improve life insurance underwriting, which stresses the urgency of policymakers to balance competing interests between stakeholders as this technology develops.

遗传风险评分人寿保险核保死亡率预测风险分类